Business Systems Consultant
About the job
- A bachelor's degree in computer science, applied and computational mathematics, data science, management information systems, electronics and/or communication engineering, analytics, a related field, or foreign education equivalent, plus five years of work experience in a combination of data analyst, data engineering, and business systems analyst roles.
- Five years of experience analyzing complex data infrastructure and data granularities, applying data visualization and iterative prototyping to define architecture, and developing secure, high-performing, scalable solutions.
- Five years of experience analyzing or engineering data using databases and Structured Query Language (SQL).
- Five years of experience designing and developing extract, transform, load (ETL) or extract, load, transform (ELT) pipelines using tools including Informatica.
- Three years of experience gathering business requirements and preparing and presenting information orally and in writing to a supervisor, non-technology stakeholders, and peers in a matrixed organization.
- Three years of experience working with Agile methodology.
- Three years of experience building data solutions using Snowflake.
- Three years of experience storing, processing, or analyzing data on cloud-based solutions.
- Three years of experience leading project initiatives and owning project delivery.
- Three years of experience performing data modeling and reviewing models, including designing enterprise-level robust data structures, validating data integrity, and ensuring models align with best practices.
- Two years of experience analyzing or transforming data with Python. Experience may be gained concurrently; suitable combinations of education, training, or experience are accepted.
- Manage project scopes, budgets, and schedules to ensure successful delivery within organizational constraints.
- Oversee milestone achievement, evaluate and recommend technology solutions, resolve conflicts, and foster collaborative relationships across teams and with external partners for optimal project outcomes.
- Lead data-driven transformation initiatives, analyze current and future business architectures, and design tailored solutions to meet evolving commercial business needs.
- Elicit and translate complex requirements, implement process improvements, maintain technical documentation, and present actionable insights to stakeholders.
- Optimize commercial data processes and ensure compliance with corporate standards to support continuous innovation and system performance across the business.
About the company
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Company Size
10,001+
Company Stage
IPO
Headquarters
North Chicago, Illinois
Founded
1888
Get referred to AbbVie
See people who can refer or advise you
Simplify's Take
What believers are saying
- Apogee acquisition closed in 2026, expanding AbbVie’s immunology pipeline beyond Skyrizi and Rinvoq.
- EU approvals for RINVOQ and EPKINLY in September 2026 broaden ex-U.S. revenue.
- JUVMO launches in October 2026, adding a fresh neuroscience revenue line.
What critics are saying
- Humira, Skyrizi, and Rinvoq concentration keeps AbbVie exposed if immunology growth slows in 2027.
- Niaspan antitrust MDL and Biocell ALCL settlements carried $1.7 billion litigation accrual by June 2026.
- Generic ubrogepant and atogepant suits threaten Ubrelvy and Qulipta exclusivity within years.
What makes AbbVie unique
- Skyrizi and Rinvoq anchor AbbVie’s post-Humira immunology franchise across 11 EU RINVOQ indications.
- JUVMO’s September 28, 2026 FDA approval gives AbbVie first-in-class Parkinson’s D1/D5 therapy.
- AbbVie pairs blockbuster cash flows with Apogee, Iambic, and Valkai deal-making.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Remote Work Options
- Flexible Work Hours
- Professional Development Budget